Detalhe da pesquisa
1.
PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study.
Int J Mol Sci
; 22(21)2021 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34769137
2.
Anti-tumor effects of deubiquitinating enzyme inhibitor PR-619 in human chondrosarcoma through reduced cell proliferation and endoplasmic reticulum stress-related apoptosis.
Am J Cancer Res
; 13(7): 3055-3066, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37559983
3.
The UCHL5 inhibitor b-AP15 overcomes cisplatin resistance via suppression of cancer stemness in urothelial carcinoma.
Mol Ther Oncolytics
; 26: 387-398, 2022 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36090476
4.
Nerolidol inhibits proliferation of leiomyoma cells via reactive oxygen species-induced DNA damage and downregulation of the ATM/Akt pathway.
Phytochemistry
; 191: 112901, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388663